Back to search
FDAFDA · Food and drugs·Recall number Z-0306-2018

Euro Diagnostica DIASTAT ANA (anti-nuclear antibody) ELISA DIASTAT ANA (anti-nuclear antibody) A positive ANA test result provides presumptive evidence for systemic rheumatic disease; further definition of specific antibody profiles is a valuable aid in the diagnostic process.

Published January 10, 2018 · Recall initiated: February 14, 2017

Summary

FDA records medical device Class II recall Z-0306-2018, published January 10, 2018 and initiated February 14, 2017. Recalling firm: Euro Diagnostica AB; Status: Terminated; Reported quantity: 534 kits; Lot: Lot: TS 2076. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Euro Diagnostica has identified a deviation in one of the components of the DIASTAT ANA (FANA200), lot TS 2076. The kit might not perform correctly and so potentially yield false positive samples.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Euro Diagnostica AB
Distributor
MN, NE, TX
Lot
Lot: TS 2076
Risk classification
Class II
Area (FDA)
device
Country
Sweden

Related recalls

Questions about this recall

Was Euro Diagnostica DIASTAT ANA (anti-nuclear antibody) ELISA DIASTAT ANA (anti-nuclear antibody) A positive ANA test result provides presumptive evidence for systemic rheumatic disease; further definition of specific antibody profiles is a valuable aid in the diagnostic process. recalled?

Yes. FDA published recall Z-0306-2018 on January 10, 2018. Reported hazard: Euro Diagnostica has identified a deviation in one of the components of the DIASTAT ANA (FANA200), lot TS 2076. The kit might not perform correctly and so potentially yield false positive samples.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail